The Differentiated Thyroid Cancer (Dtc) Therapeutics Professional Market is a high-value segment within oncology, focused on treating the most common forms of thyroid malignancy, primarily Papillary Thyroid Cancer (PTC) and Follicular Thyroid Cancer (FTC). The market encompasses various tr